AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vaccine developer Nabi Biopharmaceuticals suffered a major blow this month when a vaccine it developed to ward off staphylococcus infections, known as staph, failed to do so in its Phase III clinical trial. The Boca Raton-based company said in a press release that the majority of its development dollars this year have been spent on the vaccine, called StaphVAX, and a related product. Nabi also said it is immediately halting development, and will try to figure out why a ...